Materna Medical Launches Groundbreaking Virtual Clinical Trial Evaluating Treatment of Vaginismus Symptoms Using the Milli™ Vaginal Dilator

Written By Milli Marketing

Materna Medical is disrupting a $6 billion worth market in the most common pelvic conditions women face.



Milli Marketing
Previous

Materna Medical Announces Publication of EASE Pilot Study
Next

Materna Medical Completes First Close of Series B2 Financing Round